» Articles » PMID: 30926654

Development and Validation of a Prediction Rule for Estimating Gastric Cancer Risk in the Chinese High-risk Population: a Nationwide Multicentre Study

Abstract

Objective: To develop a gastric cancer (GC) risk prediction rule as an initial prescreening tool to identify individuals with a high risk prior to gastroscopy.

Design: This was a nationwide multicentre cross-sectional study. Individuals aged 40-80 years who went to hospitals for a GC screening gastroscopy were recruited. Serum pepsinogen (PG) I, PG II, gastrin-17 (G-17) and anti- IgG antibody concentrations were tested prior to endoscopy. Eligible participants (n=14 929) were randomly assigned into the derivation and validation cohorts, with a ratio of 2:1. Risk factors for GC were identified by univariate and multivariate analyses and an optimal prediction rule was then settled.

Results: The novel GC risk prediction rule comprised seven variables (age, sex, PG I/II ratio, G-17 level, infection, pickled food and fried food), with scores ranging from 0 to 25. The observed prevalence rates of GC in the derivation cohort at low-risk (≤11), medium-risk (12-16) or high-risk (17-25) group were 1.2%, 4.4% and 12.3%, respectively (p<0.001).When gastroscopy was used for individuals with medium risk and high risk, 70.8% of total GC cases and 70.3% of early GC cases were detected. While endoscopy requirements could be reduced by 66.7% according to the low-risk proportion. The prediction rule owns a good discrimination, with an area under curve of 0.76, or calibration (p<0.001).

Conclusions: The developed and validated prediction rule showed good performance on identifying individuals at a higher risk in a Chinese high-risk population. Future studies are needed to validate its efficacy in a larger population.

Citing Articles

Natural products based on Correa's cascade for the treatment of gastric cancer trilogy: Current status and future perspective.

Liao W, Wang J, Li Y J Pharm Anal. 2025; 15(2):101075.

PMID: 39957902 PMC: 11830317. DOI: 10.1016/j.jpha.2024.101075.


Predictors of the Development of Gastric Cancer in Post--Eradication Patients Followed Up for More than 10 Years: A Histological, Serological, and Endoscopic Study.

Mizukami K, Kodama M, Hirashita Y, Fukuda M, Ozaka S, Tsutsumi K Cancers (Basel). 2025; 17(3).

PMID: 39941917 PMC: 11816399. DOI: 10.3390/cancers17030552.


Hp eradication decreased the expression level of PG II in patients of Hp negative with gastric intestinal metaplasia: a retrospective cross-sectional study.

Wang Y, Cao X, Shan B, Chen S, Li S, Fei S J Health Popul Nutr. 2025; 44(1):20.

PMID: 39856761 PMC: 11762886. DOI: 10.1186/s41043-025-00756-y.


Development of a urine-based metabolomics approach for multi-cancer screening and tumor origin prediction.

Xu X, Zeng C, Qing B, He Y, Song G, Wang J Front Immunol. 2024; 15:1449103.

PMID: 39735533 PMC: 11671364. DOI: 10.3389/fimmu.2024.1449103.


Establishment and validation of a nomogram model for early diagnosis of gastric cancer: a large-scale cohort study.

Wang H, Ding Y, Zhao S, Li K, Li D Front Oncol. 2024; 14:1463480.

PMID: 39678515 PMC: 11638037. DOI: 10.3389/fonc.2024.1463480.


References
1.
Wang T, Dangler C, Chen D, Goldenring J, Koh T, Raychowdhury R . Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 1999; 118(1):36-47. DOI: 10.1016/s0016-5085(00)70412-4. View

2.
Schlemper R, Riddell R, Kato Y, Borchard F, Cooper H, Dawsey S . The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000; 47(2):251-5. PMC: 1728018. DOI: 10.1136/gut.47.2.251. View

3.
You W, Zhang L, Gail M, Chang Y, Liu W, Ma J . Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst. 2000; 92(19):1607-12. DOI: 10.1093/jnci/92.19.1607. View

4.
Steyerberg E, Harrell Jr F, Borsboom G, Eijkemans M, Vergouwe Y, Habbema J . Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001; 54(8):774-81. DOI: 10.1016/s0895-4356(01)00341-9. View

5.
Dixon M . Gastrointestinal epithelial neoplasia: Vienna revisited. Gut. 2002; 51(1):130-1. PMC: 1773259. DOI: 10.1136/gut.51.1.130. View